Proteolysis of CX3CL1 Impacts CX3CR1 Signaling and Therapeutic Benefits in a Tauopathy Model
Alzheimer’s disease (AD) is a progressive, neurodegenerative disorder and the most common form of dementia. The hallmark pathologies of AD are extracellular aggregates of amyloid-beta, intracellular aggregates of microtubule associated protein tau and increased neuroinflammation. Current therapeutic...
Main Author: | Finneran, Dylan John |
---|---|
Format: | Others |
Published: |
Scholar Commons
2018
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/7504 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=8701&context=etd |
Similar Items
-
Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice
by: Aimee N. Winter, et al.
Published: (2020-05-01) -
CX<sub>3</sub>CL1 (fractalkine) and CX<sub>3</sub>CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
by: Olsson Tomas, et al.
Published: (2005-07-01) -
The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
by: Paulina Pawelec, et al.
Published: (2020-10-01) -
Neuron–glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
by: Graham K. Sheridan, et al.
Published: (2013-01-01) -
Neuron to microglia communication; a study of CX3CL1 signaling implications in cognitive function, inflammation, and neurodegeneration
by: Morganti, Joshua M
Published: (2012)